Cipla USA, Inc. recalls Lanthanum Carbonate Chewable Tablets, 1000mg, 10-count bottle, Rx only, Manufactured for Exelan Pharmaceuticals, NDC 76…
- Recall date
- October 23, 2024
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- D-0044-2025
- FDA classification
- Class II
- Brand / firm
- Cipla USA, Inc.
- Sold / distributed
- USA nationwide.
Why it was recalled
Failed Tablet/Capsule Specifications: Complaints received of crushed and broken tablets.
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
Lanthanum Carbonate Chewable Tablets, 1000mg, 10-count bottle, Rx only, Manufactured for Exelan Pharmaceuticals, NDC 76282-0478-90
Get recall alerts
Free email alert whenever Cipla USA, Inc. has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Cipla USA, Inc.